Sterigmatocystin is used as an inhibitor of the G1 phase and DNA synthesis; it is employed in research to suppress p21 activity. It is also utilized as a precursor in the biosynthesis of aflatoxins and serves as a tool compound in studies investigating DNA damage, cell cycle arrest (particularly G2 arrest), and the ATM/p53-dependent signaling pathway. Additionally, it is applied in toxicological and carcinogenicity studies due to its mutagenic, teratogenic, and tumorigenic properties.